BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Prognosis
54 results:

  • 1. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
    Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
    Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. RFC5, regulated by circ_0038985/miR-3614-5p, functions as an oncogene in the progression of colorectal cancer.
    Yao H; Zhou X; Zhou A; Chen J; Chen G; Shi X; Shi B; Tai Q; Mi X; Zhou G; Wang S; Sun J; Yang X; Yang Y; Cao H; Zhou D; Sun L; Yao Y; He S
    Mol Carcinog; 2023 Jun; 62(6):771-785. PubMed ID: 36988339
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The association of blood ctDNA levels to mutations of marker genes in colorectal cancer.
    Bai F; Du Q; Zou Q; Xu L; Dong W; Lv X; Han X; Zhou H; Zhang C; Lu T
    Cancer Rep (Hoboken); 2023 Apr; 6(4):e1782. PubMed ID: 36746394
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Retrospective Analysis of Treatment Pathways in Patients With BRAF
    Gerger A; Eisterer W; Fuxius S; Bastian S; Koeberle D; Welslau M; Sanoyan DA; Maas C; Uhlig J; Fenchel K; Greil R; VON DER Heyde E; Agocs GR; Weide R; Schwager M; Reichenbach F; Modest DP; Fritsch R
    Anticancer Res; 2022 Oct; 42(10):4773-4785. PubMed ID: 36191968
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Intestinal Perforation in a Patient with Colon cancer during Treatment with Regorafenib: A Case Report and Review of the Literature.
    Ouchi R; Okada K; Usui K; Kurata N; Suzuki S; Nagao M; Watanabe Y; Koyama K
    Tohoku J Exp Med; 2021 Jul; 254(3):207-211. PubMed ID: 34321384
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Up-to-date role of aflibercept in the treatment of colorectal cancer.
    Saoudi Gonzalez N; Salvà F; Ros J; Baraibar I; Marmolejo D; Valdivia A; Cuadra-Urteaga JL; Mulet N; Tabernero J; Élez E
    Expert Opin Biol Ther; 2021 Oct; 21(10):1315-1324. PubMed ID: 34085884
    [No Abstract]    [Full Text] [Related]  

  • 7. Beyond bevacizumab: a review of targeted agents in metastatic small bowel adenocarcinoma.
    Sacdalan DB; Mendoza MJ; Vergara JP; Catedral LI; Ting FI; Leones LM; Berba CM; Sacdalan DL
    Med Oncol; 2020 Nov; 37(11):106. PubMed ID: 33135102
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. TIPE regulates vegfr2 expression and promotes angiogenesis in colorectal cancer.
    Zhong M; Li N; Qiu X; Ye Y; Chen H; Hua J; Yin P; Zhuang G
    Int J Biol Sci; 2020; 16(2):272-283. PubMed ID: 31929755
    [No Abstract]    [Full Text] [Related]  

  • 9. Relationship between SDC1 and cadherin signalling activation in cancer.
    Liao S; Liu C; Zhu G; Wang K; Yang Y; Wang C
    Pathol Res Pract; 2020 Jan; 216(1):152756. PubMed ID: 31810587
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung.
    Djureinovic D; Pontén V; Landelius P; Al Sayegh S; Kappert K; Kamali-Moghaddam M; Micke P; Ståhle E
    BMC Cancer; 2019 Jul; 19(1):741. PubMed ID: 31357969
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Anti-colorectal cancer Effect via Application of Polyethylene Glycol Modified Liposomal Apatinib.
    Hu Y; Zhou P; Lin Y; Yang D; Wang B
    J Biomed Nanotechnol; 2019 Jun; 15(6):1256-1266. PubMed ID: 31072433
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Knockdown GREM1 suppresses cell growth, angiogenesis, and epithelial-mesenchymal transition in colon cancer.
    Liu Y; Li Y; Hou R; Shu Z
    J Cell Biochem; 2019 Apr; 120(4):5583-5596. PubMed ID: 30426548
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The Prognostic Value of the Combination of Low vegfr-1 and High vegfr-2 Expression in Endothelial Cells of colorectal cancer.
    D'Haene N; Koopmansch C; Van Eycke YR; Hulet F; Allard J; Bouri S; Rorive S; Remmelink M; Decaestecker C; Maris C; Salmon I
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423986
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [The impact of genetic variation of kdr on clinical outcomes of advanced colorectal cancer patients treated by first line bevacizumab based regimens].
    Wang HX; Mei X; Gong TX; Han N; Liu P; Wang J; Zhang ZM
    Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(34):2737-2742. PubMed ID: 30220171
    [No Abstract]    [Full Text] [Related]  

  • 15. Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients.
    Delgado-Ureña M; Ortega FG; de Miguel-Pérez D; Rodriguez-Martínez A; García-Puche JL; Ilyine H; Lorente JA; Exposito-Hernandez J; Garrido-Navas MC; Delgado-Ramirez M; Serrano MJ
    J Transl Med; 2018 Sep; 16(1):251. PubMed ID: 30189880
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Effective treatment of apatinib in desmoplastic small round cell tumor: a case report and literature review.
    Shi C; Feng Y; Zhang LC; Ding DY; Yan MY; Pan L
    BMC Cancer; 2018 Mar; 18(1):338. PubMed ID: 29587657
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. vegfr2 regulates endothelial differentiation of colon cancer cells.
    Liu Z; Qi L; Li Y; Zhao X; Sun B
    BMC Cancer; 2017 Aug; 17(1):593. PubMed ID: 28854900
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. CPEB4 immunohistochemical expression is associated to prognosis in stage IV colorectal carcinoma.
    Cortés-Guiral D; Pastor-Iodate C; Díaz Del Arco C; Del Puerto-Nevado L; Fernández-Aceñero MJ
    Pathol Res Pract; 2017 Jun; 213(6):639-642. PubMed ID: 28551384
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Lymphangiogenesis and colorectal cancer.
    Huang C; Chen Y
    Saudi Med J; 2017 Mar; 38(3):237-244. PubMed ID: 28251217
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. CCL24 contributes to HCC malignancy via RhoB- VEGFA-vegfr2 angiogenesis pathway and indicates poor prognosis.
    Jin L; Liu WR; Tian MX; Jiang XF; Wang H; Zhou PY; Ding ZB; Peng YF; Dai Z; Qiu SJ; Zhou J; Fan J; Shi YH
    Oncotarget; 2017 Jan; 8(3):5135-5148. PubMed ID: 28042950
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.